has role EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor hypoglycemic agent anti-arrhythmia drug glyburide Diabeta Glyburide 494.00400 glibenclamidum DrugBank:DB01016 1-((p-(2-(5-chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea KEGG:D00336 0 glibenclamida Glynase glibenclamide ZNNLBTZKUZBEKO-UHFFFAOYSA-N Patent:NL6610580 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide CAS:10238-21-8 493.14382 Patent:NL6603398 Drug_Central:1314 Patent:US3454635 CHEBI:5441 PMID:20797618 InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29) 5-chloro-N-(2-{4-[N-(N-cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1 Wikipedia:Glibenclamide Micronase Beilstein:2230085 An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group. PMID:16081479 C23H28ClN3O5S LINCS:LSM-2811 KEGG:C07022 chebi_ontology 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea N-sulfonylurea EC 2.7.1.33 (pantothenate kinase) inhibitor monochlorobenzenes